Pipeline & HCV UK-CAB 31 January 2009.

Slides:

Advertisements

Similar presentations

Future Trials of Hepatitis C Therapy in the HIV Co-infected Stephen D. Shafran, MD, FRCPC, FACP Department of Medicine, Division of Infectious Diseases.

Advertisements

Hepatitis web study Hepatitis web study Telaprevir in Treatment Experienced GT-1 REALIZE (Study 216) Phase 3 Treatment Experienced Zeuzem S, et al. N Engl.

Hepatitis web study Hepatitis web study Sofosbuvir, Ribavirin, GS-0938 in GT 1-4 QUANTUM Phase 2b Treatment Naïve Lalezari JP, et al. EASL. 2013; Abstract.

Hepatitis web study Hepatitis web study Telaprevir in Treatment Naïve GT-1 ADVANCE (Study 108) Phase 3 Treatment Naïve Jacobson IM, et. al. N Engl J Med.

Hepatitis web study Hepatitis web study Sofosbuvir + Peginterferon + Ribavirin in Genotypes 1,4,5,6 ATOMIC Phase 2 Treatment Naïve Kowdley K, et al. Lancet.

Hepatitis web study Hepatitis web study Daclatasvir + Sofosbuvir +/- Ribavirin in Genotypes 1-3 A Trial Phase 2a Treatment Naïve and Treatment.

Hepatitis web study Hepatitis web study Telaprevir in Treatment Naïve GT-1 ILLUMINATE (Study 111) Phase 3 Treatment Naïve Sherman KE, et. al. N Engl J.

Phase Difference = Phase Difference = 0.05.

Phase 3 Treatment Naïve and Treatment Experienced Renal Disease

ALAN FRANCISCUS EXECUTIVE DIRECTOR, HEPATITIS C SUPPORT PROJECT EDITOR-IN-CHIEF, HCV ADVOCATE WEBSITE JOIN ME ON TWITTER & FACEBOOK – HCVADVOCATE BLOG:

Update on the HCV Antiviral Pipeline Todd S. Wills, MD SPNS HCV Treatment Expansion Initiative Evaluation and Technical Assistance Center Infectious Disease.

When to Initiate ART in Adults and Adolescents (2009 WHO Guidelines) Target PopulationClinical conditionRecommendation Asymptomatic Individuals (including.

Hepatitis web study Hepatitis web study Telaprevir BID versus q8 in Treatment Naïve GT-1 OPTIMIZE (Study C211) Phase 3 Treatment Naïve Buti M, et al. Gastroenterology.

Virology Education, P: F: , E: June 2011, Milan Marriott Hotel, Milan,

Hepatitis web study Hepatitis web study Simeprevir + Sofosbuvir in GT1 with Cirrhosis OPTIMIST-2 Trial Phase 3 Treatment Naïve and Treatment Experienced.

Sulkowski M. Lancet 2015;385: C-WORTHY  Design Randomisation* Open-label > 18 years HCV genotype 1, treatment naïve HCV RNA ≥ 10,000 IU/ml No cirrhosis.

Hepatitis web study Hepatitis web study Daclatasvir + Sofosbuvir +/- Ribavirin in Genotype 1-3 AI Trial Phase 2a Treatment-Naïve and Treatment-Experienced.

Luís Mendão European AIDS Treatment Group, GAT/H-CAB ELPA Symposium Compassionate use programs for hepatitis C patients with advanced disease Saturday,

基督再來（一）. 經文： 1 你們心裡不要憂愁；你們信神，也當信我。 2 在我父的家裡有許多住處；若是沒有，我就早已告訴你們了。我去原是為你們預備地去。 3 我若去為你們預備了地方，就必再來接你們到我那裡去，我在那裡，叫你們也在那裡， ] ( 約 14 ： 1-3)

Hepatitis C Past, present and future Salil Singh Consultant Gastroenterologist, RBH

SOF/VEL 400/100 mg qd N = 106 W12 > 18 years Chronic HCV infection Genotype 1-6 Naïve or pre-treatment with IFN-based regimen Compensated cirrhosis allowed*

ΜΕΤΑΣΥΛΛΕΚΤΙΚΗ ΦΥΣΙΟΛΟΓΙΑ ΕΡΓΑΣΤΗΡΙΟ 3. Μετασυλλεκτική Εργ3-Λιοσάτου Γ.2 ΒΙΟΛΟΓΙΚΟΙ ΠΑΡΑΓΟΝΤΕΣ ΠΟΥ ΕΠΗΡΕΑΖΟΥΝ ΤΗ ΦΘΟΡΑ ΤΩΝ ΟΠΩΡΟΚΗΠΕΥΤΙΚΩΝ Αναπνοή Η λειτουργία.

Treatment of HBV/HCV Coinfection

Phase 3 Treatment Experienced

Hepatitis C Consultation Services (844) | 9AM-5PM ET, M-F nccc.ucsf.edu The Clinician Consultation Center (CCC) provides up-to-date expert clinical.

Interim Analysis of a 3-Year Follow-up Study of NS5A and NS3 Resistance-Associated Variants After Treatment With Grazoprevir-Containing Regimens in Patients.

EASL Recommendations on Treatment of Hepatitis C 2015 Treatment recommendations for HCV-monoinfected or HCV/HIV coinfected patients with chronic hepatitis.

Daclatasvir + Sofosbuvir +/- Ribavirin in Genotype 1-3 Trial

Volume 63, Issue 1, Pages (July 2015)

ARV-trial.com Switch to ATV/r + 3TC ATLAS-M Study.

Volume 61, Issue 4, Pages (October 2014)

Future Trials of Hepatitis C Therapy in the HIV Co-infected

Sofosbuvir plus Peg-Interferon and Ribavirin in Treatment Experienced Patients with Hepatitis C Virus and HIV Co-Infection Mehri Nikbin, MD Infectious.

Phase 2 Treatment Naïve HIV Coinfection

Lesson 3: The HCV Care Continuum

SOF/VEL + GS-9857 in genotypes 1-6 Phase II

HIV/HCV Co-Infection Case

Chronic Hepatitis C Virus Infection

The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America Present HCV Guidance: Recommendations for Testing,

مبررات إدخال الحاسوب في رياض الأطفال

Pharmacokinetics and Drug Interactions in the new HCV Clinical Management SOC.

بِسْمِ اللّهِ الرَّحْمَنِ الرَّحِيمِ )وَإِذَا مَرِضْتُ فَهُوَ يشْفِينِ( )سورة الشعراء – الاية 80) صدق الله العظيم.

Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals Susanna Naggie, Mark S. Sulkowski Gastroenterology

فرایند تسهیلگری در مددکاری جامعه ای

Phase 3 Treatment Naïve HIV Coinfection

Nathalie Adda, Doug J. Bartels, Linda Gritz, Tara L

What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?

The presenters from Medivir at the Carnegie lunch January 21 Lars Adlersson CEO Prof Bertil Samuelsson, VP Discovery and Research Rein Piir, CFO /

اثرات گرمايش جهاني تغييرات آب و هوا، تأثيرات عميق و شديدي بر بسياري از عوامل اساسي موثر بر سلامت از جمله : آب، غذا، هوا و محيط زيست دارد كه اين مورد خود.

Слайд-дәріс Қарағанды мемлекеттік техникалық университеті

Care of the Treatment-naive Patient With HCV/HIV Coinfection

.. -"""--..J '. / /I/I =---=-- -, _ --, _ = :;:.

Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective.

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection Anaïs Vallet-Pichard,

Elbasvir/Grazoprevir plus Sofosbuvir ± Ribavirin in Treatment-naive and Treatment-experienced Patients with Hepatitis C Virus Genotype 3 Infection and.

II //II // \ Others Q.

21twelveinteractive.com/ twitter.com/21twelveI/ facebook.com/21twelveinteractive/ linkedin.com/company/21twelve-interactive/ pinterest.com/21twelveinteractive/

Phase 3 Treatment Naïve and Treatment Experienced HIV Coinfection

I1I1 a 1·1,.,.,,I.,,I · I 1··n I J,-·

Update From Seattle 2017.

Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H

What do data in monoinfection mean in relation to co-infection?

Volume 142, Issue 6, Pages (May 2012)

REAL-WORLD SAFETY, EFFECTIVENESS, AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION TREATED WITH GLECAPREVIR/PIBRENTASVIR:

Volume 132, Issue 1, Pages 5-6 (January 2007)

Volume 63, Issue 1, Pages (July 2015)

Alessio Aghemo, Maria Francesca Donato Gastroenterology

. '. '. I;.,, - - "!' - -·-·,Ii '.....,,......, -,

Lesson 3: The HCV Care Continuum

Presentation transcript:

Pipeline & HCV UK-CAB 31 January 2009

Pipeline TMC435 Hepatitis C RSV353 (Respiratory Syncitial Virus) Phase II-a, small cohorts, cohort 5. News @ EASL Phase II-b later in 2009 RSV353 (Respiratory Syncitial Virus) Phase I

Hepatitis C: Telaprevir. Co-development with VERTEX. Sponsored and managed by Vertex 1050 Treatment-naïve patients. Sponsored and managed by TIBOTEC 650 Treatment-failure patients

Studies for HIV/HCV coinfected patients DDI studies ongoing. Tenofovir: no significant interaction Coinfection study: pilot study will start this year Synopsis of protocol has been sent to ECAB for review US Community has seen and commented